According to foreign reports, the policy of restricting the effects of flavored e-cigarettes and other tobacco products (including menthol cigarettes) on the health differences of vulnerable groups is a new research topic carried out by the medical school of the University of Kentucky in the United States. The five-year, US $2.8 million grant from the National Cancer Institute (NCI) will support the study to explore how local policies affect high-risk groups more likely to use oriental tobacco products, including people of color, low-income groups and youth groups.
The study's lead researcher, Dr. shyanika rose, a faculty member at the center for health equity transition (Chet), said the results could help legislators develop more equitable policies. "We already know that stopping selling these products will reduce the availability and usage of these communities," Rose said. However, understanding the impact of policies of different races and socio-economic status will guide what kind of policies work and have the most equitable benefits. "
Flavored tobacco products, including nebulizers and e-cigarettes, are more attractive, easier to use and more addictive, and have long been disproportionately marketed to vulnerable groups, especially African Americans, Dr. rose said. Currently, federal law only prohibits the sale of certain spice tobacco products.
Menthol cigarettes and all smokeless tobacco, cigars and water pipes are still allowed to be sold. Although the food and Drug Administration recently announced new measures to ban the sale of menthol cigarettes and flavored cigars, the proposal will not eliminate all flavored tobacco products from the market, especially flavored e-cigarettes and e-liquids.
"While the FDA is pushing federal policy in the right direction, a comprehensive policy that limits the sale of all spice tobacco products may be more likely to protect the health of the most vulnerable groups, which is what this project will investigate," Dr. rose said